Patent ID: 7888310

Claim:
A method of identifying patients to be treated by dopamine agonist therapy comprising the steps of: analyzing a plasma or urine sample from said patient for concentrations of norepinephrine (NE), norepinephrine metabolites (NE metabolites), dopamine, dopamine metabolites, serotonin, serotonin metabolites, or fasting triglycerides, wherein one or more of: a) NE metabolites, b) NE or NE metabolites: dopamine or dopamine metabolites, c) NE and serotonin, d) NE or NE metabolites and serotonin, e) NE and serotonin metabolites, f) NE or NE metabolites and serotonin metabolites, or g) NE, is/are greater than about 30% over normal level; or dopamine or dopamine metabolites are less than about 30% below normal; or fasting triglycerides are greater than about 150 mg/dl and/or said patient has blood pressure of greater than about 135/85 mm Hg.